Identification of P2X 3 and P2X 7 purinergic receptors activated by ATP in rat lacrimal gland

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3254-3263

  Hodges, Robin R ^a   Vrouvlianis, Joanna ^a   Scott, Rachel ^a   Dartt, Darlene A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PEROXIDASE; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X7 RECEPTOR; CALCIUM; DRUG DERIVATIVE; FURA 2; NF023; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; SURAMIN; ZINC;

ACINAR CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; LACRIMAL APPARATUS; METABOLISM; PH; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOTTING, WESTERN; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FURA-2; HYDROGEN-ION CONCENTRATION; LACRIMAL APPARATUS; MALE; PURINERGIC P2X RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2X1; RECEPTORS, PURINERGIC P2X3; RECEPTORS, PURINERGIC P2X7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURAMIN; ZINC;

EID: 79961041715     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7042     Document Type: Article

References (39)

1. Dartt DA. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009;28:155-177.
2. Hodges RR, Dartt DA. Regulatory pathways in lacrimal gland epithelium. Int Rev Cytol. 2003;231:129-196.
3. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 2007;64:1471-1483.
4. Gomes DA, Song Z, Stevens W, Sladek CD. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors. Am J Physiol Regul Integr Comp Physiol. 2009;297:R940-R949.
5. North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82:1013-1067.
6. King BF, Wildman SS, Ziganshina LE, Pintor J, Burnstock G. Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor. Br J Pharmacol. 1997;121:1445-1453.
7. Ma B, Ruan HZ, Burnstock G, Dunn PM. Differential expression of P2X receptors on neurons from different parasympathetic ganglia. Neuropharmacology. 2005;48:766-777.
8. Tittle RK, Hume RI. Opposite effects of zinc on human and rat P2X2 receptors. J Neurosci. 2008;28:11131-11140.
9. Hodges RR, Vrouvlianis J, Shatos MA, Dartt DA. Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland. Invest Ophthalmol Vis Sci. 2009;50:5681-5689.
10. Shibuya I, Tanaka K, Hahori Y, et al. Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones. J Physiol. 1999;514(pt 2):351-367.
11. Sun B, Li J, Okahara K, Kambayashi J. P2X1 purinoceptor in human platelets: molecular cloning and functional characterization after heterologous expression. J Biol Chem. 1998;273:11544-11547.
12. Suzuki-Kerr H, Vlajkovic S, Donaldson PJ, Lim J. Molecular identification and localization of P2X receptors in the rat lens. Exp Eye Res. 2008;86:844-855.
13. Yunaev MA, Barden JA, Bennett MR. Changes in the distribution of different subtypes of P2X receptor clusters on smooth muscle cells in relation to nerve varicosities in the pregnant rat urinary bladder. J Neurocytol. 2000;29:99-108.
14. 2+in mouse embryonic stem cell-derived GABAergic neurons. Br J Pharmacol. 2009;158:1922-1931.
15. Judkins CP, Sobey CG, Dang TT, et al. NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors. J Pharmacol Exp Ther. 2006;317:644-650.
16. Corriden R, Insel PA. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal. 2010;3(104):re1.
17. Darby M, Kuzmiski JB, Panenka W, Feighan D, MacVicar BA. ATP released from astrocytes during swelling activates chloride channels. J Neurophysiol. 2003;89:1870-1877.
18. Wang Y, Roman R, Lidofsky SD, Fitz JG. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci U S A. 1996;93:12020-12025.
19. Piccini A, Carta S, Tassi S, et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A. 2008;105:8067-8072.
20. Sauer H, Hescheler J, Wartenberg M. Mechanical strain-induced Ca(2+) waves are propagated via ATP release and purinergic receptor activation. Am J Physiol Cell Physiol. 2000;279:C295-C307.
21. Gourine AV, Wood JD, Burnstock G. Purinergic signalling in autonomic control. Trends Neurosci. 2009;32:241-248.
22. Nagaya N, Tittle RK, Saar N, Dellal SS, Hume RI. An intersubunit zinc binding site in rat P2X2 receptors. J Biol Chem. 2005;280: 25982-25993.
23. Acuna-Castillo C, Morales B, Huidobro-Toro JP. Zinc and copper modulate differentially the P2X4 receptor. J Neurochem. 2000;74: 1529-1537.
24. Lewis C, Neidhart S, Holy C, et al. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 1995;377:432-435.
25. Spelta V, Jiang LH, Surprenant A, North RA. Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors. Br J Pharmacol. 2002;135:1524-1530.
26. Burgard EC, Correa-Medina M, Cabrero O, et al. Competitive antagonism of recombinant P2X(2/3) receptors by 2+, 3+-O-(2,4,6-trinitrophenyl) adenosine 5+-triphosphate (TNP-ATP). Mol Pharmacol. 2000;58:1502-1510.
27. Burnstock G. Purinergic receptors and pain. Curr Pharm Des. 2009;15:1717-1735.
28. Jacques-Silva MC, et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci U S A. 2010;107:6465-6470.
29. Dartt DA, Rose PE, Joshi VM, Donowitz M, Sharp GW. Role of calcium in cholinergic stimulation of lacrimal gland protein secretion. Curr Eye Res. 1985;4:475-483.
30. 2+, Pyk2, and c-Src in agonist activation of rat lacrimal gland p42/p44 MAPK. Invest Ophthalmol Vis Sci. 2006;47:3352-3359.
31. 2+signaling by cholinergic and α1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome. Clin Immunol Immunopathol. 1998;89:134-140.
32. 2+elevation in rat lacrimal gland acini is negatively modulated by PKCdelta and PKCepsilon. Invest Ophthalmol Vis Sci. 2000;41:386-392.
33. Turner JT, Landon LA, Gibbons SJ, Talamo BR. Salivary gland P2 nucleotide receptors. Crit Rev Oral Biol Med. 1999;10:210-224.
34. Casas-Pruneda G, Reyes JP, Perez-Flores G, Perez-Cornejo P, Arreola J. Functional interactions between P2X4 and P2X7 receptors from mouse salivary epithelia. J Physiol. 2009;587(pt 12):2887-2901.
35. Brown DA, Bruce JI, Straub SV, Yule DI. cAMP potentiates ATPevoked calcium signaling in human parotid acinar cells. J Biol Chem. 2004;279:39485-39494.
36. Mamenko MV, Chizhmakov IV, Volkova TM, Verkhratsky A, Krishtal OA. Extracellular cAMP inhibits P2X receptors in rat sensory neurones through G protein-mediated mechanism. Acta Physiol. 2010;199:199-204.
37. Funaki C, Hodges RR, Dartt DA. Role of cAMP inhibition of p44/ p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland. Am J Physiol Cell Physiol. 2007; 293:C1551-C1560.
38. Dartt DA, Baker AK, Vaillant C, Rose PE. Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am J Physiol. 1984;247(pt 1):G502-G509.
39. Hodges RR, Zoukhri D, Sergheraert C, Zieske JD, Dartt DA. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest Ophthalmol Vis Sci. 1997;38:610-619.